Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Downgrades NexImmune to Market Perform

Raymond James analyst Steven Seedhouse downgrades NexImmune (NASDAQ:NEXI) from Outperform to Market Perform.
byBenzinga Newsdesk
November 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst Steven Seedhouse downgrades NexImmune (NASDAQ:NEXI) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Toll Brothers Apartment Living And Pondmoon Capital Holdings USA Announce Joint Venture To Develop 285-Unit Luxury Rental Community In Frisco, Texas; Financed Through A $49.5M Construction Loan Facility From Santander Bank N.A

By Happy Mohamed
January 30, 11:03 AM
Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation's leading builder of luxury homes, through its Toll Brothers Apartment Living rental division, and Pondmoon Capital USA have announced a new joint venture

TOL